Progress on development of vaccines against 2019-nCoV / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
; (6): 13-20, 2021.
Article
en Zh
| WPRIM
| ID: wpr-884829
Biblioteca responsable:
WPRO
ABSTRACT
Since the outbreak of COVID-19 caused by the 2019-nCoV (SARS-CoV-2), with its high pathogenicity and contagiousness, it has posed a serious threat to global public health security. Up to now, the pathogenesis of 2019-nCoV is unclear, and there is no effective treatment. Vaccine as one of the most effective strategies to prevent virus infection has become a hot area. Based on the current understanding of 2019-nCoV, the development of 2019-nCoV vaccines covers all types inactivated virus vaccine, recombinant protein vaccine, viral vector-based vaccine, mRNA vaccine, and DNA vaccine, etc. In this review, we focus on the candidate targets of the novel coronavirus, and the types, development status and progress of 2019-nCoV vaccines in order to provide information for further research and prevention.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Clinical Infectious Diseases
Año:
2021
Tipo del documento:
Article